7TVH
Hyperlytic variant of Tae1, Type VI secretion amidase effector 1, from Pseudomonas aeruginosa (Cys110Ser)
Summary for 7TVH
Entry DOI | 10.2210/pdb7tvh/pdb |
Descriptor | Peptidoglycan amidase Tse1 (2 entities in total) |
Functional Keywords | type vi secretion amidase effector, tae1 hyperlytic variant, cys110ser, antimicrobial protein, hydrolase |
Biological source | Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) |
Total number of polymer chains | 4 |
Total formula weight | 70055.05 |
Authors | Radkov, A.,Saunders, H.,Chou, S. (deposition date: 2022-02-04, release date: 2022-07-06, Last modification date: 2023-10-25) |
Primary citation | Radkov, A.,Sapiro, A.L.,Flores, S.,Henderson, C.,Saunders, H.,Kim, R.,Massa, S.,Thompson, S.,Mateusiak, C.,Biboy, J.,Zhao, Z.,Starita, L.M.,Hatleberg, W.L.,Vollmer, W.,Russell, A.B.,Simorre, J.P.,Anthony-Cahill, S.,Brzovic, P.,Hayes, B.,Chou, S. Antibacterial potency of type VI amidase effector toxins is dependent on substrate topology and cellular context. Elife, 11:-, 2022 Cited by PubMed: 35762582DOI: 10.7554/eLife.79796 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.71 Å) |
Structure validation
Download full validation report